BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 314100)

  • 1. [Immunological status of patients with Hodgkin's disease after splenectomy].
    Glińska H; Turowski G; Radziszewska J
    Nowotwory; 1979; 29(2):93-104. PubMed ID: 314100
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of splenectomy and radiotherapy on lymphocytes in Hodgkin's disease.
    Sutherland RM; McCredie JA; Inch WR
    Clin Oncol; 1975 Dec; 1(4):275-84. PubMed ID: 1082407
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of radiochemotherapy and splenectomy on cellular immunity in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma.
    Steele R; Han T
    Cancer; 1978 Jul; 42(1):133-9. PubMed ID: 667791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of splenectomy on cellular immunologic parameters in Hodgkin's disease.
    Wagener DJ; Geestman E; Borgonjen A; Haanen C
    Cancer; 1976 May; 37(5):2212-9. PubMed ID: 130968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunity in Hodgkin's lymphoma].
    Danieli G; Montroni M; Leoni P; Magelli L; Totti S
    G Clin Med; 1975; 56(1):39-56. PubMed ID: 770222
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of splenectomy on the invitro lymphocyte response to phytohemagglutinin and pokeweed mitogen in Hodgkin's disease.
    Wagener DJ; Geestman E; Wessels HM
    Cancer; 1975 Jul; 36(1):194-8. PubMed ID: 1203846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
    Pappas A; Pees H; Girmann G
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodeficiencies in Hodgkin's Disease. Part II: B cell immunity, complement systems and phagocytic cell systems.
    Gupta S
    Clin Bull; 1981; 11(3):110-9. PubMed ID: 7039866
    [No Abstract]   [Full Text] [Related]  

  • 9. Increase of T lymphocytes in the spleen in Hodgkin's disease.
    Kaur J; Spiers AS; Catovsky D; Galton DA
    Lancet; 1974 Oct; 2(7884):800-2. PubMed ID: 4138221
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long term effects of splenectomy on the immune-status of Hodgkin's disease patients depending on the modality of treatment (author's transl)].
    Schaadt M; Diehl V; Kalden JR; Schmidt N; Laskewitz E
    Med Klin; 1978 Oct; 73(40):1381-8. PubMed ID: 309061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up studies on the immune status of patients with Hodgkin's disease after splenectomy and treatment, in relapse and remission.
    Hancock BW; Bruce L; Dunsmore IR; Ward AM; Richmond J
    Br J Cancer; 1977 Sep; 36(3):347-54. PubMed ID: 921891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.
    Gajl-Peczalska KJ; Bloomfield CD; Sosin H; Kersey JH
    Clin Exp Immunol; 1976 Jan; 23(1):47-55. PubMed ID: 1083318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamics of the immunological indices in lymphogranulomatosis following splenectomy and radiation therapy].
    Ankudinov VA; Asliaev LA; Khvorostenko MI; Krugovov BA; Kosse VA
    Vopr Onkol; 1981; 27(4):26-31. PubMed ID: 7233871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodeficiency in Hodgkin's disease and its relation to prognosis.
    Björkholm M
    Scand J Haematol Suppl; 1978; 33():1-74. PubMed ID: 305101
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term influence of splenectomy on immune functions in patients with Hodgkin's disease.
    Björkholm M; Askergren J; Holm G; Mellstedt H
    Scand J Haematol; 1980 Jan; 24(1):87-94. PubMed ID: 6966069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer factor in Hodgkin's disease.
    Ng RP; Moran CJ; Alexopoulos CG; Bellingham AJ
    Lancet; 1975 Nov; 2(7941):901-3. PubMed ID: 53376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disorders of cellular immunity in Hodgkin's disease].
    Burchardt K
    Pol Arch Med Wewn; 1981 Aug; 66(2):133-41. PubMed ID: 7033936
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemolytic anemia in Hodgkin's disease].
    Kühböck J; Aiginger P; Pötzi P; Smolen J
    Acta Med Austriaca; 1979; 6(5):186-9. PubMed ID: 555213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses to tests of cell mediated immunity before, during and after BCG administration in Hodgkin's disease.
    Lenzini L; Bracci R; Rottoli P; Rottoli L
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:300. PubMed ID: 4546904
    [No Abstract]   [Full Text] [Related]  

  • 20. [Proportions and absolute count of T- and B-lymphocytes in peripheral blood and their blastic transformation induced by mitogens in splenectomized and non-splenectomized patients with Hodgkin's disease].
    Pluzańska A
    Acta Haematol Pol; 1978; 9(1):37-44. PubMed ID: 307325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.